BioSpace News Archive

Three years ago, the U.S. Food and Drug Administration announced the most comprehensive reform to the Nutrition Facts label since its introduction in 1993.

With the help of philanthropic support for regenerative medicine and biomedical research, Dr. Robin Robinson, Ph.D., the first director of the Biomedical Advanced Research and Development Authority (BARDA) and former deputy Assistant Secretary for Preparedness and Response at the Department of Health and Human Services (HHS), was named a Fellow with the Thought Leadership & Innovation Foundation (TLI)

CognitiveRx™ uses machine learning to monitor market demand signals, predict shortage risk and recommend optimal inventory levels

In a life-saving leap for THE BIG ASK: THE BIG GIVE (BABG) platform, designed to increase kidney transplantation and living donation, the National Kidney Foundation (NKF) has expanded its BABG trainings to 15 additional markets across the country, thanks to a new partnership with the Fresenius Medical Care Foundation (FMCF).

Specialized driving instructors stress life skill development, parent-supervised practice, and individualized training to enhance learning and independence

Her Excellency the Right Honourable Julie Payette, Governor General of Canada, will present the Canadian Institutes of Health Research 2018 Gold Leaf Prizes to four laureates during a ceremony at Rideau Hall, on Thursday, June 20, 2019, at 10:30 a.m.

At this year’s HFMA Annual Conference, healthcare financial leaders seeking to replace costly and inefficient solutions are encouraged to meet with Recondo Technology, the pioneer of healthcare revenue cycle automation.

Piper Jaffray Companies (NYSE: PJC), a leading investment bank and institutional securities firm with one of Wall Street’s most active and awarded healthcare practices, will host the 7th annual Heartland Summit on June 20, 2019 in Minneapolis.

Company has submitted clinical trial authorization (CTA) application to initiate a Phase I study of its fully owned 4-1BB antibody ATOR-1017 for the treatment of metastasizing cancer.

While pregnancy and birth rates continue to decline for 15 to 19-year-olds, putting them at historic lows, Minnesota youth are contracting sexually transmitted infections at alarmingly high rates.